{
  "name": "Movement Disorders",
  "slug": "movement-disorders",
  "icon": "üîÑ",
  "color": "bg-green-100 text-green-800 border-green-200",
  "toc": [
    {
      "level": 1,
      "text": "Examination",
      "id": "examination"
    },
    {
      "level": 1,
      "text": "Tremor",
      "id": "tremor"
    },
    {
      "level": 1,
      "text": "Ataxias",
      "id": "ataxias"
    },
    {
      "level": 1,
      "text": "Work-up for Cerebellar Dysfunction",
      "id": "work-up-for-cerebellar-dysfunction"
    },
    {
      "level": 3,
      "text": "Dystonia",
      "id": "dystonia"
    },
    {
      "level": 3,
      "text": "Dystonia",
      "id": "dystonia-2"
    },
    {
      "level": 1,
      "text": "Dystonia Treatment",
      "id": "dystonia-treatment"
    },
    {
      "level": 1,
      "text": "Chorea",
      "id": "chorea"
    },
    {
      "level": 1,
      "text": "Tics",
      "id": "tics"
    }
  ],
  "html": "<h1 id=\"examination\">Examination</h1><div class=\"table-wrap\"><table><tbody><tr><td></td><td><p><strong>Exam Maneuver</strong></p></td><td><p><strong>Examples of Abnormalities</strong></p></td></tr><tr><td><p><strong>General</strong></p></td><td><p>Quiet sitting w/ &amp; w/o suppression</p></td><td><p>Abnormal movements present at rest</p><p>Titubation (bobbing of head and/or trunk)</p></td></tr><tr><td><p><strong>Cranial Nerves</strong></p></td><td><p>Fixation of Gaze</p></td><td><p>Nystagmus</p><p>Impairment with maintaining gaze</p><p>Square Wave Jerks</p></td></tr><tr><td></td><td><p>Smooth Pursuit</p></td><td><p>Breakdown with jerky saccades</p></td></tr><tr><td></td><td><p>Large saccades</p></td><td><p>Over- or undershooting</p><p>Blink to initiate saccade</p></td></tr><tr><td></td><td><p>Speech</p><p>-Coordination of sounds</p><p>-Quality of sound</p><p>-Pronunciation</p><p>-Modulation of pitch</p><p>-Inflection</p><p>-Holding ‚Äòaah‚Äô and ‚Äòeeh‚Äô sounds</p></td><td><p>Dysrhythmia / Clumsy and Ataxic</p><p>Dysarthric for labial, lingual &amp;/or guttural sounds</p><p>Scanning speech / abnormal prosody</p><p>Tremor</p><p>Soft, strangulated, or breathy</p></td></tr><tr><td></td><td><p>Tongue movements side to side</p></td><td><p>Slow</p></td></tr><tr><td><p><strong>Motor</strong></p></td><td><p>Tone</p></td><td><p>Spastic / Rigid / Dystonia/ Hypotonia</p></td></tr><tr><td></td><td><p>Arms Extended with palms up, in, down and out</p></td><td><p>Tremor</p><p>Abnormal Postures or Movements</p><p>Rebound (when examiner forces extended arms downward)</p></td></tr><tr><td></td><td><p>Rapid Alternating Movements</p></td><td><p>Abnormal Postures in part moving</p><p>Abnormal Postures in non-moving part</p><p>Dysdiadochokinesia / Clumsy Coordination</p><p>Slow Speed</p><p>Low or diminishing Amplitude</p><p>Abnormal Rhythm</p><p>Superimposed Abnormal Movements</p></td></tr><tr><td></td><td><p>Finger-to-Nose and Toe-to-Finger</p></td><td><p>Ataxia</p><p>Dysmetria</p><p>Tremor throughout (action) or as approach target (intention tremor)</p><p>Superimposed Abnormal Movements (chorea or myoclonus)</p></td></tr><tr><td></td><td><p>Writing</p></td><td><p>Abnormal Postures of Hands</p><p>Tremor</p><p>Superimposed Abnormal Movements</p></td></tr><tr><td></td><td><p>Exam Maneuver </p></td><td><p>Examples of Abnormalities</p></td></tr><tr><td><p><strong>Gait</strong></p></td><td><p>Body Posture</p></td><td><p>Trunk Flexed / Trunk Extended</p></td></tr><tr><td></td><td><p>Base</p></td><td><p>Wide / Narrow (Scissored)</p></td></tr><tr><td></td><td><p>Stride Length</p></td><td><p>Asymmetric, Short</p></td></tr><tr><td></td><td><p>Arm Swing</p></td><td><p>Asymmetric</p></td></tr><tr><td></td><td><p>Heel-Toe Progression</p></td><td><p>No heel strike</p></td></tr><tr><td></td><td><p>Path</p></td><td><p>Meanders</p></td></tr><tr><td></td><td><p>Tandem</p></td><td><p>Balance impairment</p></td></tr><tr><td></td><td><p>Balance on one foot</p></td><td><p>Balance impairment</p></td></tr><tr><td></td><td><p>Foot posture</p></td><td><p>Abnormal</p></td></tr><tr><td></td><td><p>Reverse/Sideways walking</p></td><td><p>Abnormal movements persist</p></td></tr><tr><td></td><td><p>While walking any abnl movts</p></td><td><p>Increased abnormal movements</p></td></tr></tbody></table></div><div class=\"table-wrap\"><table><tbody><tr><td><p><strong>Hyperkinetic movements</strong></p><p><strong>(Excess of movement)</strong></p></td><td><p><strong>Hypokinetic movements</strong></p><p><strong>(reduction of movement)</strong></p></td></tr><tr><td><p>Stereotypies</p></td><td><p>Parkinsonism</p></td></tr><tr><td><p>Myoclonus</p></td><td></td></tr><tr><td><p>Tremor</p></td><td></td></tr><tr><td><p>Dystonia</p></td><td></td></tr><tr><td><p>Chorea</p></td><td></td></tr><tr><td><p>Tics</p></td><td></td></tr></tbody></table></div><p>How to describe the movement:</p><ul><li>Hyper- or hypo-kinetic?</li><li>Frequency of movement? i.e. intermittent, continuous</li><li>Duration?</li><li>Voluntary vs. involuntary?</li><li>Occur at rest or with movement? </li><li>Suppressible?</li></ul><p>Important questions:</p><ul><li>Any change in the movement?</li><li>Decompensation during voluntary movement?</li><li>Premonitory urge?</li><li>Family history?</li></ul><h1 id=\"tremor\">Tremor</h1><p><strong>Postural</strong> &gt; Resting    </p><ul><li>Regular<ul><li>+ Family history√† Electrolytes and TFTs</li><li>No family history √† Above and MRI brain</li></ul></li><li>Irregular and jerking<ul><li>Consider myoclonic or dystonic tremor and corresponding syndromes</li></ul></li></ul><p><strong>Resting</strong> &gt; Postural</p><ul><li>Conversion or Parkinsonian</li></ul><div class=\"table-wrap\"><table><tbody><tr><td><p><strong>Etiology of action tremor- both columns are causes</strong></p></td><td></td></tr><tr><td><p>Familial essential tremor</p></td><td><p>Weakness</p></td></tr><tr><td><p>Genetic such as</p><p>      Myoclonus-dystonia syndrome</p><p>      Dystonias / CMT</p><p>     chromosomal abnormalities</p></td><td><p>Peripheral neuropathy</p></td></tr><tr><td><p>Cerebellar tremor</p></td><td><p>Psychogenic </p></td></tr><tr><td><p><strong>Etiology of action tremor</strong></p></td><td></td></tr><tr><td><p>Meds/drugs/tox</p><p> albuterol, amiodarone, VPA amphetamines, arsenic, caffeine, cocaine, cyanide, cyclosporine, ethanol, lead, lindane, Li++, TCAs</p><p>manganese, mercury, nicotine naphthalene, tolune, thyroxine</p></td><td><p>Metabolic</p><p>hepatic encephalopathy, hyperthyroidism,</p><p>hypocalcemia, hypoglycemia,</p><p>hypomagnesemia, pheochromocytoma</p><p>mitochondrial</p></td></tr></tbody></table></div><h1 id=\"ataxias\">Ataxias</h1><div class=\"table-wrap\"><table><tbody><tr><td></td><td><p><strong>ACUTE-ONSET ATAXIA: in previously healthy children</strong></p></td></tr><tr><td><p><strong>Etiology</strong></p></td><td><p><strong>Typical Presentation</strong></p></td></tr><tr><td><p>Drug or Med Ingestion</p></td><td><p>1-4 yo may have nystagmus &amp; encephalopathy</p></td></tr><tr><td><p>Cerebellitis</p></td><td><p>Acute severe ataxia, MS change, concern for cerebellar swelling; can see URI antecedent</p></td></tr><tr><td><p>Basilar Migraine</p></td><td><p>Other accompanying migrainous features</p></td></tr><tr><td><p>Benign Paroxysmal Vertigo</p></td><td><p>Other accompanying migrainous features</p></td></tr><tr><td><p>Brainstem Encephalitis</p></td><td><p>CN dysfunction, encephalopathy, szs, vomit</p></td></tr><tr><td><p>Neuroblastoma (paraneoplastic)</p></td><td><p>Encephalopathy, irritability, opsoclonus, distal myoclonus</p></td></tr><tr><td><p>Conversion Reaction</p></td><td><p>Inconsistent exam, late 1<sup>st</sup> early 2<sup>nd</sup> decade of life</p></td></tr><tr><td><p>Trauma: Hematoma, Post-Concussive</p></td><td><p>Antecedent history</p></td></tr><tr><td><p>Vertebrobasilar Artery Occlusion</p></td><td><p>Mute, quadriplegia, aware, communicate w/eyes; Can have initial transient headache, hemiparesis, involuntary movements</p></td></tr><tr><td><p>Inflammatory: MS, Miller-Fisher variant of Guillain-Barre, Kawasaki Disease</p></td><td><p>MS: none, MF: CN palsies and loss of DTRs, KD: fevers and characteristic skin findings</p></td></tr><tr><td><p>Cerebellar Hemorrhage</p></td><td><p>Often with signs of increased ICP</p></td></tr><tr><td></td><td><p><strong>RECURRENT ATAXIA: may be on background of slowly progressive ataxia</strong></p></td></tr><tr><td><p><strong>Etiology</strong></p></td><td><p><strong>Typical Presentation</strong></p></td></tr><tr><td><p><strong>Episodic Ataxia, Type I</strong></p></td><td><p>AD inheritance, 5-7 yo at onset, attacks 10 min-6 hours, myokymia in hands between attacks. Genetic testing commercially available. Acetazolamide reduces attacks.</p></td></tr><tr><td><p><strong>Episodic Ataxia, Type II</strong></p></td><td><p>AD inheritance, onset late childhood/ adolescence, attacks last hours, unable to maintain posture, vomiting. <em>CACNA1A</em> gene testing commercially available. Acetazolamide reduces attacks.</p></td></tr><tr><td><p><strong>Hartnup Disease</strong></p></td><td><p>Slow development, photosensitive pellagra-like rash, episodes of ataxia, +/- nystagmus, and mood changes to encephalopathy. Increased tone and DTRs. Episodes of worsening due to stress or infection. Aminoaciduria. Treat with niacin.</p></td></tr><tr><td><p><strong>MSUD (Intermittent)</strong></p></td><td><p>Irritability, progressive lethargy, attacks provoked by infxn, surgery or protein meal, onset 5 mo-2 yo. Aminoaciduria. Diet: arginine, benzoate and alpha-ketoacids.</p></td></tr><tr><td><p><strong>Pyruvate Dehydrogenase Deficiency</strong></p></td><td><p>Presents after 3 yrs, episodes of ataxia, dysarthria, possible with weakness and lethargy, may be spontaneous or provoked by infection, stress or high-carbohydrate meal, lasts hrs to wks. Elevated CSF lactate, skin biopsy for dx (although females may have false negative due to mosaicism). Treat with ketogenic diet and possibly CoQ10, carnitine, Vit E and C, alpha lipoic acid.</p></td></tr><tr><td><p><strong>Glut-1 Deficiency Syndrome</strong></p></td><td><p>+/- H/o seizures and encephalopathy, may occur following a fast, with accompanying lethargy, hypotonia and weakness. CSF glucose &lt;40 mg/dL. Treat with ketogenic diet and possibly CoQ10, carnitine, Vit E and C, alpha lipoic acid.</p></td></tr><tr><td><p><strong>Migraine</strong></p></td><td><p>Typically, with other migrainous features. Treat as for classic migraine.</p></td></tr><tr><td><p><strong>Pseudoataxia (epileptic)</strong></p></td><td><p>Sudden onset with associated confusion, no nystagmus. EEG suggestive. Treat with AEDs.</p></td></tr></tbody></table></div><div class=\"table-wrap\"><table><tbody><tr><td><p><strong>CHRONIC ATAXIA: typically, slowly progressive. </strong></p></td><td></td></tr><tr><td><p><strong>Structural:</strong></p></td><td></td></tr><tr><td><p>Congenital lesions: cerebellar aplasia, hypoplasia, vermian or hemisphere aplasia, Chiari or Dandy-Walker malform. basilar impression</p></td><td></td></tr><tr><td><p><strong>Autosomal Recessive Ataxias:</strong></p></td><td></td></tr><tr><td><p>Friedreich Ataxia</p></td><td><p>Marinesco-Sjogren</p></td></tr><tr><td><p>Ataxia Telangiectasia</p></td><td><p>Maple Syrup Urine Disease</p></td></tr><tr><td><p>Ataxia with Vitamin E Deficiency</p></td><td><p>Multiple Carboxylase Deficiency</p></td></tr><tr><td><p>Abetalipoproteinemia (Bassen-Kornzweig)</p></td><td><p>Juvenile Sulfatide Lipidosis (Metachromatic Leukodystrophy)</p></td></tr><tr><td><p>Ataxia-Oculomotor Apraxia 1</p></td><td><p>Ramsay Hunt Syndrome</p></td></tr><tr><td><p>Ataxia-Oculomotor Apraxia 2</p></td><td><p>Refsum Disease</p></td></tr><tr><td><p>Ataxia with Diffuse CNS Hypomyelination (vanishing white matter)</p></td><td><p>Respiratory Chain Disorders (Complex I, III, IV)</p></td></tr><tr><td><p>Glut-1 Deficiency Syndrome</p></td><td><p>Pyruvate Dehydrogenase Def</p></td></tr><tr><td><p>Hartnup Disease</p></td><td><p>Juvenile GM2 Gangliosidosis</p></td></tr><tr><td><p>Sea-Blue Histiocytoses, including Niemann-Pick</p></td><td></td></tr><tr><td><p><strong>Autosomal Dominant Ataxias:</strong></p></td><td></td></tr><tr><td><p>Dentatorubral-pallidoluysian atrophy </p></td><td><p>Spinocerebellar Ataxias (&gt;25 described)</p></td></tr><tr><td><p>Hypobetalipoproteinemia, Areflexia and Retinitis Pigmentosa (HARP)</p></td><td></td></tr><tr><td><p><strong>X-linked:</strong></p></td><td></td></tr><tr><td><p>Adrenoleukodystrophy</p></td><td><p>Pelizaeus-Merzbacher Disease</p></td></tr><tr><td><p>Leber Hereditary Optic Neuropathy</p></td><td></td></tr><tr><td><p><strong>CHRONIC ATAXIA: typically, slowly progressive.</strong></p></td><td></td></tr><tr><td><p><strong>Genetic, variable inheritance:</strong></p></td><td></td></tr><tr><td><p>Hereditary Spastic Ataxias</p></td><td><p>Inflammatory Disease: Multiple Sclerosis</p></td></tr><tr><td><p><strong>Neoplastic: </strong></p></td><td></td></tr><tr><td><p>Cerebellar Astrocytoma</p></td><td><p>Ependymoma</p></td></tr><tr><td><p>Cerebellar Hemangioblastoma (Von Hippel-Lindau)</p></td><td><p>Medulloblastoma  </p></td></tr><tr><td><p>Supratentorial Tumors</p></td><td></td></tr></tbody></table></div><h1 id=\"work-up-for-cerebellar-dysfunction\">Work-up for Cerebellar Dysfunction</h1><ul><li>Acute: <ul><li>CT scan, Utox, CMP</li><li>Consider MRI/MRA if concern for stroke or vascular lesion</li><li>Consider LP if encephalopathic and neg scan, or suspect infectious or inflammatory etiology</li><li>MIBG scan, urine HVA and VMA, and chest/abd/pelvis CT +/- contrast if suspect paraneoplastic (such as opsoclonus myoclonus ataxia secondary to neuroblastoma), LP and serum paraneoplastic panels</li></ul></li><li>Recurrent<ul><li>MRI, MRA, MRS</li><li>Consider LP for CSF glucose if MRI normal</li><li>Additional genetic and metabolic testing based on results of above and clinical features</li></ul></li><li>Chronic<ul><li>MRI +/- MRA, MRS</li><li>Vitamin E level</li><li>Consider LP pending MRI result, to check glucose, OCB and IgG index, lactate and pyruvate</li><li>Additional genetic and metabolic work-up based on results of above and clinical features</li></ul></li></ul><p>Recall that many SCAs (AD cerebellar ataxias), Fragile X, and Friedreich Ataxia are repeat expansion diseases and will NOT be evaluated on WES.. </p><h3 id=\"dystonia\">Dystonia</h3><h3 id=\"dystonia-2\"><strong>Dystonia </strong></h3><ul><li>An abnormal twisting posture of one or more body part caused by the contraction of muscles which contract and extend a joint <em>at the same time</em>. </li><li>Most children with dystonia are quite strong in the dystonic limbs. </li><li>It is usually increased by action (such as writing, walking or running), with stress, mental activities but may also be present at rest when severe. </li><li>Can be seen with one specific e.g. writer‚Äôs cramp</li><li>Sensory trick: something a person does to help improve or resolve the dystonia like touching the extremity, putting a popsicle stick in mouth (example of a sensory trick in a child who had neck dystonia)</li></ul><p>Dystonia can be a primary disorder or a secondary. Primary dystonias are typically genetic disorders that can present at characteristic ages across the lifespan.  Secondary dystonia results from underlying brain disease, injury or medication usage. </p><p><strong>Treatment </strong></p><p><strong>Goal: </strong>decrease dystonia enough to improve motor control without causing worsening secretions, further impaired swallowing, increased weakness or excessive sedation. </p><p>Often children are on multiple medications for dystonia and also receiving injections of botulinum toxin and/or phenol. </p><ul><li><strong>Trihexyphenidyl (Artane) titration:</strong></li></ul><p>Week 1: 0.05 mg/kg BID</p><p>Week 2: 0.05 mg/kg TID</p><p>Week 3: 0.1 mg/kg TID</p><p>Week 4: 0.15 mg/kg TID</p><p>Week 5: 0.2 mg/kg TID</p><p>Weeks 6 &amp; on: 0.25 mg/kg TID</p><p>If side effects occur, try slowing down the titration.  Can take many weeks to months for benefit to be seen.  Consider keeping patients on medication for up to 6 months to evaluate for benefit.</p><p>Side Effects: mydriasis, blurred vision, dry mouth, urinary retention, constipation, and rarely dizziness or slowed cognition.</p><p>‚Ä¢ <strong>Baclofen</strong> is a muscle relaxant medication but also works in the brain to reduce abnormal signals in the basal ganglia and spinal cord. Potential side effects: sedation, trunk and head muscle weakness, worsened swallowing</p><p>‚Ä¢ <strong>Clonazepam (Klonopin) </strong>and <strong>Diazepam (Valium)</strong> are benzodiazepines. Potential side effects: sedation, irritability, increased secretions</p><p>‚Ä¢ <strong>Carbidopa-Levodopa (Sinemet)</strong> is a dopamine precursor. Potential side effects: nausea and vomiting, sedation, constipation, light-headedness</p><p><strong>Titration example (refer to weight-based dosing in the medication table at the end of the dystonia pathway table and round to the nearest quarter tab, liquid also available; the ‚ÄúAbnormal Movement‚Äù Order Set in Epic has weight-based Sinemet titration orders)</strong></p><p><strong>Carbidopa/Levodopa (Sinemet) titration:</strong></p><p>Medication: Carbidopa/Levodopa 25 mg/100 mg </p><div class=\"table-wrap\"><table><tbody><tr><td></td><td><p><strong>Breakfast</strong></p></td><td><p><strong>Lunch</strong></p></td><td><p><strong>Dinner</strong></p></td></tr><tr><td><p>Now</p></td><td><p>0</p></td><td><p>0</p></td><td><p>0</p></td></tr><tr><td><p>Week 1</p></td><td><p>half tablet</p></td><td><p>0</p></td><td><p>0</p></td></tr><tr><td><p>Week 2</p></td><td><p>half tablet</p></td><td><p>half tablet</p></td><td><p>0</p></td></tr><tr><td><p>Week 3</p></td><td><p>half tablet</p></td><td><p>half tablet</p></td><td><p>half tablet</p></td></tr><tr><td><p>Week 4</p></td><td><p>1 tablet</p></td><td><p>half tablet</p></td><td><p>half tablet</p></td></tr><tr><td><p>Week 5</p></td><td><p>1 tablet</p></td><td><p>1 tablet</p></td><td><p>half tablet</p></td></tr><tr><td><p>Week 6 &amp; on</p></td><td><p>1 tablet</p></td><td><p>1 tablet</p></td><td><p>1 tablet</p></td></tr></tbody></table></div><p>Possible Sinemet Side Effects: nausea, light-headedness, sedation, constipation, abnormal dreams</p><p>Take with food. For persistent nausea, add carbidopa (Lodosyn) at 12.5 to 25 mg TID with each carbidopa/levodopa dose.</p><p>‚Ä¢ <strong>Oxcarbazepine (Trileptal)</strong> is a seizure medication which acts at sodium channels in the brain. Potential side effects: sedation, lowers serum sodium, stomach upset, rash</p><p>‚Ä¢ <strong>Levetiracetam (Keppra)</strong> is a seizure medication. Potential side effects: irritability, sleepiness or insomnia</p><p>‚Ä¢ <strong>Phenobarbital </strong>is a barbiturate seizure medication, Potential side effects: sedation, elevated liver enzymes</p><p>‚Ä¢ <strong>Valproic acid (Depakene, Depakote)</strong> is a seizure medication. Potential side effects: sedation, tremor, weight gain, potential for liver enzymes, pancreatitis, anemia and platelet dysfunction</p><p>‚Ä¢ <strong>Tetrabenazine (Xenazine)</strong> is a dopamine-depleting medication. Potential side effects: drowsiness, depression, parkinsonism (slow movements, rigid muscles)</p><p>‚Ä¢ <strong>Sertraline (Zoloft)</strong> is a specific-serotonin reuptake inhibitor. Potential side effects: insomnia or sedation, upset stomach, mania, suicidality</p><p><strong>Muscle Injections:</strong></p><p>‚Ä¢ <strong>Botulinum toxin (Botox):</strong> this toxin weakens the connection between the nerve and the muscle, thereby weakening the muscle. There is benefit in certain types of dystonia, with only minimal weakening of the muscle. The goal of injections of botulinum toxin is to reduce the symptoms of dystonia, without causing significant muscle weakness. Toxin injections usually need to be repeated every 3 to 6 months. In younger children, the procedure may require sedation or anesthesia</p><p>‚Ä¢ <strong>Phenol:</strong> this medication is stronger than botulinum toxin and is often used for larger muscle groups in the legs. It is quite painful when injected and therefore is only done under anesthesia. This may be used in combination with botulinum toxin injections. </p><p><strong>Surgical Options (for refractory cases):</strong></p><p>‚Ä¢ <strong>Intrathecal Baclofen Pump:</strong> this infuses baclofen directly onto the spinal cord through a catheter implanted underneath the skin which is connected to a pump the size of a hockey puck placed in the abdomen. It does not have the side effect of sleepiness that high doses of oral baclofen may have. Typically, it works much better for spasticity rather than dystonia, but when there is a combined picture, doing an intrathecal baclofen test dose where a small dose of baclofen is infused either once (with a spinal tap) or continuously (with a catheter) and the tone is then reassessed over the next several hours to evaluate for a response. </p><p>‚Ä¢ <strong>Deep Brain Stimulation Surgery:</strong> this surgery implants electrodes into the brain to interfere with the inappropriate basal ganglia signals electrically (rather than chemically as medications do). The electrodes are connected via a wire implanted underneath the skin to a brain pacemaker placed in the chest. The pacemaker is programmed over the course of weeks to months to achieve the best effect on dystonia. Works best for mobile dystonia rather than fixed postures with contractures</p><h1 id=\"dystonia-treatment\">Dystonia Treatment </h1><p>Allen M, Lin J-P, Lynch T, King M. Status dystonicus: a practice guide. Developmental &amp; Child Neurology. 2013 Dec; Vol 56, Issue 2. P. 105-112, Fig 1. <a href=\"https://doi.org/10.1111/dmcn.12339\"><strong>https://doi.org/10.1111/dmcn.12339</strong></a></p><p><strong><em>Oral Medications for the Treatment of Dystonia</em></strong></p><p><em>For outpatient initiation: start low and titrate to the lowest effective dose for symptom control with tolerable side effects. To minimize side effects, start with divided dose given daily and titrate to BID-QID [depending on t1/2].</em></p><p><em> Dosing information below is based on available literature in pediatric patients for dystonia/spasticity. If no dosing information was available for these indications, Lexi-comp dosing for other indications for pediatric patients was used</em></p><div class=\"table-wrap\"><table><tbody><tr><td><p><em>Medication</em></p></td><td><p><em>Titration</em></p></td><td><p><em>Peds Dosing</em></p></td><td><p><em>Dosage Forms</em></p></td><td><p><em>Side Effects</em></p></td><td><p><em>MISC</em></p></td></tr><tr><td><p>Trihexyphenidyl [Artane]</p><p>MOA: Anti-cholinergic</p></td><td><p>Starting dose</p><p>Increase by</p><p>Goal dose</p></td><td><p>0.1-0.2 mg/kg/day divided TID; started daily-BID &amp; increased weekly to TID</p><p>0.05-0.3 mg/kg/day weekly</p><p>0.05-0.5 mg/kg/day divided TID [max 0.75 mg/kg/day]; up to 2.6 mg/kg/day reported)</p></td><td><p>Tabs: 2mg, 5mg</p><p>Solution: 0.4mg/mL</p></td><td><p>Central: dizziness, N/V, behavioral &amp; cognitive ‚àÜ, anx, chorea, insom., nightmares</p><p>Peripheral: constipation, urinary retent., dry mouth, blurred vision</p></td><td><p>CI: narrow angle glaucoma</p><p>Paradoxical effects may occur at low doses</p><p>2-4 weeks to see full benefit</p></td></tr><tr><td><p>Baclofen [Lioresal]</p><p>MOA: GABA<sub>B </sub>agonist</p></td><td><p>Starting dose</p><p>Increase by</p><p>Goal dose</p></td><td><p>‚â•4 mo-&lt;2 yrs: 2.5 mg qHS</p><p>2 yrs-7 yrs: 2.5-5 mg qHS</p><p>‚â•8 years: 5 mg qHS</p><p>(0.3 mg/kg/day divided BID or TID)</p><p>2.5-5 mg/day q3 days-weekly</p><p>(0.1-0.3 mg/kg/day divided TD;</p><p>Goal 1-2 mg/kg/day)</p><p>&lt;2 yrs: 10-20 mg/day divided TID; max 40 mg/day</p><p>2-7 yrs: 20-30 mg/daily divided TID; max 60 mg/day</p><p>‚â•8 yrs: 30-40 mg/day divided TID; Max 200 mg/day; reports up to 240 mg/day</p></td><td><p>Tabs: 5mg, 10mg, 20mg</p><p>First oral cmpd susp kit: 1mg/mL, 5mg/mL</p></td><td><p>Sedation, dizziness, nausea, fatigue</p></td><td><p>Avoid abrupt DC to prevent withdrawal</p></td></tr><tr><td><p>Medication</p></td><td><p>Titration</p></td><td><p><em>Peds Dosing</em></p></td><td><p><em>Dosage Forms</em></p></td><td><p><em>Side effects</em></p></td><td><p><em>MISC</em></p></td></tr><tr><td><p>Clonazepam [Klonopin]</p><p>MOA: GABA<sub>A </sub>agonist</p></td><td><p>Starting dose</p><p>Increase by</p><p>Goal dose</p></td><td><p>&lt;30 kg: 0.01-0.03 mg/kg/day divided TID-QID;</p><p>‚â•30 kg: ‚â§0.25 mg/dose TID</p><p>&lt;30 kg: 0.01-0.03 mg/kg/day q3-5 days;</p><p>‚â•30 kg: 0.5-1 mg/day q3-5 days</p><p>0.05-0.2 mg/kg/day divided TID</p></td><td><p>Tabs: 0.5mg, 1mg, 2mg</p><p>ODT: 0.125mg, 0.25mg, 0.5mg, 1mg, 2mg</p><p>Solu (CMPD): 0.1mg/mL</p></td><td><p>Sedation, depression, nocturnal drooling, behavioral disinhibition</p></td><td><p>Avoid abrupt DC to prevent withdrawal</p></td></tr><tr><td><p>Diazepam [Valium]</p><p>MOA: GABA<sub>A </sub>agonist</p></td><td><p><em>Starting dose</em></p><p><em>Increase by</em></p><p><em>Goal dose</em></p></td><td><p>0.1-0.3 mg/kg/day divided BID-QID (max 10 mg/dose)</p><p>0.1 mg/kg/day weekly</p><p>0.8 mg/kg/day divided BID-QID</p><p>&gt;12 yrs: 2-10 mg/dose BID-QID</p></td><td><p>Tabs: 2mg, 5mg, 10mg</p><p>Solu: 5mg/mL</p></td><td><p>Sedation, depression, nocturnal drooling, behavioral disinhibition</p></td><td><p>Avoid abrupt DC to prevent withdrawal</p></td></tr><tr><td><p>Gabapentin [Neurontin, Gralise]</p><p><em>MOA: </em>Structurally related to GABA. Binds to Œ±2-delta subunit of voltage-gated Ca channels</p></td><td><p><em>Starting dose</em></p><p><em>Increase by</em></p><p><em>Goal dose</em></p></td><td><p>10-15 mg/kg/day divided TID</p><p>Titrate to effective dose based on tolerability</p><p>60 mg/kg/day divided TID; Mean dose reported in dystonia: 18 mg/kg/dose TID</p></td><td><p>Tabs: 300mg, 600mg, 800mg</p><p>Caps: 100 mg, 300mg, 400mg</p><p>Solu: 250mg/5 mL</p></td><td><p>Sedation, emotional lability, nystagmus, tremor, ataxia, swelling</p></td><td><p>Dose adj. in renal imp. Higher doses than doses used for neuropathic pain/sz may be necessary</p></td></tr><tr><td><p>Pregabalin [Lyrica]</p><p>MOA: Structurally related to GABA. Binds to Œ±2-delta subunit of voltage-gated Ca channels</p></td><td><p><em>Starting dose</em></p><p><em>Increase by</em></p><p><em>Goal dose</em></p></td><td><p>1 mg/kg/day qHS</p><p>1 mg/kg/day q3-5 days</p><p>3-6 mg/kg/dose BID-TID</p></td><td><p>Caps: 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg, 300mg</p><p>Tabs XR: 82.5mg, 165mg, 330mg</p><p>Solu: 20mg/mL</p></td><td><p>Sedation, emotional lability, nystagmus, tremor, ataxia, swelling</p></td><td><p>XR bioavailability reduced when taken on empty stomach</p></td></tr><tr><td><p><em>Medication</em></p></td><td><p><em>Titration</em></p></td><td><p><em>Peds Dosing</em></p></td><td><p>Dosage Forms</p></td><td><p><em>Side Effects</em></p></td><td><p><em>MISC</em></p></td></tr><tr><td><p>Carbidopa/</p><p>Levodopa [Sinemet, Rytary, Duopa]</p><p>MOA: Levodopa ‚Üí dopamine in CNS, carbidopa inhibits peripheral breakdown of levodopa</p></td><td><p><em>Starting dose</em></p><p><em>Increase by</em></p><p><em>Goal dose</em></p></td><td><p>1 mg/kg/day (based on levodopa; generally start with AM/noon doses)</p><p>1 mg/kg/day weekly</p><p>4-5 mg/kg/day divided TID</p><p>(6-10 mg/kg/day in autosomal recessive DRD). Doses up to 16-20 mg/kg reported</p></td><td><p>Tabs IR: 25/100mg</p></td><td><p>GI upset, N, ortho HTN, fatigue, insomnia.</p><p>Rare w/dystonia tx: constipation dyskinesias, hallucinations</p></td><td><p>Avoid abrupt DC to prevent withdrawal. 1-3 month trial rec. If co-admin w/iron, separate doses by ‚â•2h. Give last dose no later than @1600 to reduce insomnia. Can give additional carbidopa with each dose to minimize GI ADR.</p></td></tr><tr><td><p>Tetrabenazine [Xenazine]</p><p>MOA: Reversible VMAT2 Inhibitor: monoaminergic depletion &amp; dopamine antagonist</p></td><td><p><em>Starting dose</em></p><p><em>Increase by</em></p><p><em>Goal dose</em></p></td><td><p>3.125-12.5 mg/day (generally AM)</p><p>3.125-12.5 mg/day weekly increasing to TID dosing</p><p>37.5-50 mg divided TID; doses up to 200 mg/day reported</p></td><td><p>Tabs: 12.5mg, 25mg</p></td><td><p>Sedation, parkinsonism, depression, akathisia, nervousness, insomnia, suicidal ideation</p></td><td><p>CYP2D6 genotyping rec. for doses &gt;50 mg/day</p></td></tr><tr><td><p>Deutetrabenazine [Austedo]</p><p>MOA: VMAT2 Inhibitor</p></td><td><p><em>Starting dose</em></p><p><em>Increase by</em></p><p><em>Goal dose</em></p></td><td><p>A: 6 mg daily (generally AM)</p><p>A: 6 mg/day weekly to effect</p><p>A: Doses &gt;12 mg divide BID Max: 48 mg/day</p></td><td><p>Tabs: 6mg, 9mg, 12mg</p></td><td><p>Sedation, parkinsonism, depression, akathisia, nervousness, insomnia</p></td><td><p>Available Brand only. Baseline EKG and after dose &gt;24 mg/day. Consider CYP2D6 genotyping</p></td></tr><tr><td><p>Valbenazine [Ingrezza]</p><p>MOA: VMAT2 Inhibitor</p></td><td><p><em>Starting dose</em></p><p><em>Increase by</em></p><p><em>Goal dose</em></p></td><td><p>A: 40 mg daily (generally AM)</p><p>A: Weekly to 80 mg daily</p><p>A: 80 mg daily</p></td><td><p>Caps: 40mg, 80mg</p></td><td><p>Sedation, parkinsonism, depression, akathisia, nervousness, insomnia</p></td><td><p>Available Brand only. Dose adj. for CYP3A4 &amp; 2D6 inducer/inhibitor</p></td></tr><tr><td><p>Oxcarbazepine (Trileptal)</p><p>MOA: Na channel blocker</p></td><td><p><em>Starting dose</em></p><p><em>Increase by</em></p><p><em>Goal dose</em></p></td><td><p>5mg/kg/day given daily for the first week</p><p>5 mg/kg/day weekly to effect (div BID)</p><p>5-20mg/kg/day div BID</p></td><td><p>Susp: 60mg/ml (lemon)</p><p>Tab: 150, 300, 600mg</p><p>XR: 150, 300, 600mg</p></td><td><p>Sedation, N/V, hypoNA, rash, (ataxia, diplopia-esp at high levels)</p></td><td><p>Generally pts respond to lower dosing than w/ epilepsy; hepatic metabolism; weak CYP inducer (dec OCPs)</p></td></tr><tr><td><p><em>Medication</em></p></td><td><p>Titration</p></td><td><p>Peds Dosing</p></td><td><p><em>Dosage Forms</em></p></td><td><p><em>Side Effects</em></p></td><td><p><em>MISC</em></p></td></tr><tr><td><p>Pimozide [Orap]</p><p><em>MOA: </em>Centrally acting dopamine receptor antagonist</p></td><td><p><em>Starting dose</em></p><p><em>Increase by</em></p><p><em>Goal dose</em></p></td><td><p>1 mg qHS</p><p>1 mg/weekly</p><p>2-6 mg/day divided TID; max 10 mg/day; reports up to 12 mg/day</p></td><td><p>Tabs: 1mg, 2mg</p></td><td><p>EKG ‚àÜ</p></td><td><p>Baseline and periodic EKG monitoring. CYP2D6 genotyping for doses &gt;0.05 mg/kg/day</p></td></tr><tr><td><p>Haloperidol [Haldol]</p><p><em>MOA: </em>Nonselective dopamine antagonist</p></td><td><p><em>Starting dose</em></p><p><em>Increase by</em></p><p><em>Goal dose</em></p></td><td><p>15-40 kg: 0.25-0.5 mg qHS</p><p>&gt;40 kg: 0.5 mg qHS</p><p>0.25-0.5 mg/dose weekly</p><p>0.05-0.075 mg/kg/day divided BID-TID</p><p>&gt;40 kg: 0.5-15 mg/day divided BID-TID</p></td><td><p>Tabs: 0.5mg, 1mg, 2mg,</p><p>5mg, 10mg, 20mg</p><p>Solu: 2mg/mL</p></td><td><p>HA, sedation, N/V, GI sxs, emotional hypersensitivity, dizziness, EPS, EKG ‚àÜ</p></td><td><p>Baseline and periodic EKG monitoring rec.</p></td></tr><tr><td><p>Amantadine [Gocovri]</p><p><em>MOA: </em>Glutaminergic antagonist w/multiple mechanism; NMDA receptor antagonist, direct &amp; indirect dopamine effects</p></td><td><p><em>Starting dose</em></p><p><em>Increase by</em></p><p><em>Goal dose</em></p></td><td><p>&lt;40 kg: 2.5 mg/kg/dose daily</p><p>‚â•40kg: 100 mg BID</p><p>&lt;40 kg: increase to 5 mg/kg/day divided BID after 1 week</p><p>&gt;40 kg: titrate to response; max 400 mg/day</p><p>5-8 mg/kg/day divided BID-TID; max 400 mg/day</p></td><td><p>Tabs IR: 100mg</p><p>Caps IR: 100mg</p><p>Caps ER: 68.5mg, 137mg</p></td><td><p>N, dizziness, insomnia, sedation, confusion, dry mouth, HA, orthostatic HTN, agitation, irritability, suicidal ideation</p></td><td><p>Dose adj. in renal imp.</p></td></tr><tr><td><p>Clonidine [Catapres, Kapvay]</p><p><em>MOA: </em>Œ±2-adrenergic agonist</p></td><td><p><em>Starting dose</em></p><p><em>Increase by</em></p><p><em>Goal dose</em></p></td><td><p>1-2 <strong>mcg</strong>/kg/dose qHS-TID</p><p>1-2 <strong>mcg</strong>/kg/day q3-5 days</p><p>2-4 <strong>mcg</strong>/kg/dose TID-QID; 20 <strong>mcg</strong>/kg/day divided q 4-6 hours reported</p></td><td><p>Tabs: 0.1mg, 0.2mg, 0.3mg</p><p>Tabs ER: 0.1mg</p><p>Solu (CMPD): 20mcg/mL</p><p>TTS: 0.1mg, 0.2mg, 0.3mg/24hrs</p></td><td><p>Sedation, bradycardia, hypotension</p></td><td><p>Avoid abrupt DC to prevent withdrawal symptoms &amp; rebound HTN</p></td></tr><tr><td><p><em>Medication</em></p></td><td><p>Titration</p></td><td><p>Peds Dosing</p></td><td><p><em>Dosage forms</em></p></td><td><p><em>Side Effects</em></p></td><td><p><em>MISC</em></p></td></tr><tr><td><p>Tizanidine [Zanaflex]</p><p>MOA: Œ±2-adrenergic agonist</p></td><td><p><em>Starting dose</em></p><p><em>Increase by</em></p><p><em>Goal dose</em></p></td><td><p>‚â•2-10 yrs: 1 mg qHS</p><p>‚â•10 yrs: 2 mg qHS</p><p>Titrate to effective dose based on tolerability</p><p>0.3-0.5 mg/kg/day divided TID-QID; max 24 mg/day</p></td><td><p>Tabs: 2mg, 4mg, 6mg</p><p>Caps: 2mg, 4mg, 6mg</p></td><td><p>Sedation, hypotension, dizziness, dry mouth</p></td><td><p>Avoid abrupt DC. Dose adj. in hepatic imp.</p></td></tr><tr><td><p>Dantrolene [Dantrium]</p><p>MOA: Skeletal muscle relaxant</p></td><td><p><em>Starting dose</em></p><p><em>Increase by</em></p><p><em>Goal dose</em></p></td><td><p>‚â•5 yrs: 0.5 mg/kg/day qHS-BID</p><p>0.5-1 mg/kg/day weekly</p><p>12 mg/kg/day divided TID-QID; max: 400 mg/day</p></td><td><p>Caps: 25mg, 50mg, 100mg</p></td><td><p>Sedation, dizziness, fatigue, diarrhea</p></td><td><p>Can mix capsule contents w/ juice/H20</p></td></tr></tbody></table></div><h1 id=\"chorea\">Chorea</h1><ul><li><strong>Definition</strong> - Unsustained rapid irregular non-patterned asymmetric movements that are purposeless. Most difficult to distinguish from cortical myoclonus.  Typically, no urge and not suppressible. </li><li>On examination, ask patient to sit completely at rest, chorea is typically present distally in fingers and toes <strong>and increases</strong> with purposeful movement of involved body part. </li></ul><p><strong>DDX Acute/Subacute Chorea</strong></p><div class=\"table-wrap\"><table><tbody><tr><td><p>Autoimmune</p></td><td><p>Poststreptococcal/Sydenham chorea</p><p>SLE</p></td><td><p>Antiphospholipid antibody </p><p>Henoch-Schonlein Purpura</p></td></tr><tr><td><p>Infection/ encephalitis</p></td><td><p>Mycoplasma</p><p>Lyme</p></td><td><p>HSV</p><p>TB</p></td></tr><tr><td><p>Vascular/Hypoxic ischemic</p></td><td><p>Stroke/moya-moya</p><p>Vasculitis</p><p>‚ÄúPost pump chorea‚Äù Post cardiac transplantation</p><p>Choreic CP</p></td><td><p>Exacerbated dyskinesia with febrile illness</p><p>Complex Migraine</p><p>Alternating hemiplegia</p></td></tr><tr><td><p>Metabolic</p></td><td><p>MELAS</p></td><td><p>Acute basal ganglia injury</p></td></tr><tr><td><p>Toxins</p></td><td><p>Carbon Monoxide</p></td><td></td></tr><tr><td><p>Endocrine</p></td><td><p>Thyroid and parathyroid</p><p>Pregnancy</p></td><td><p>Hypocalcemia, hypomagnesium, hypo/hypernatremic</p><p>OCPs</p></td></tr><tr><td><p>Acute and Paroxysmal</p></td><td><p>Paroxysmal kinesiogenic dyskinesia</p><p>Paroxysmal non-kinesiogenic Dyskinesia</p></td><td><p>Paroxysmal exercise-induced chorea (Glut 1)</p></td></tr><tr><td><p>Iatrogenic</p></td><td><p>Dopamine receptor blocking agents/ Neuroleptics /antipsychotics</p><p>Acute tardive, Withdrawl-emergent</p><p>Psychostimulants</p></td><td><p>Anti-convulsants</p><p>Lithium, lamictal, and methadone</p></td></tr><tr><td><p>Drug-Induced</p><p>Amphetamines and Stimulants</p></td><td><p>Amphetamine </p><p>w/ Dextroamphetamine= Adderall</p><p>Atomoxetine (Strattera)</p><p>Dexmethylphenidate (Focalin)</p></td><td><p>Dextroamphetamine (Dexedrine)</p><p>Methamphetamine (Desoxyn)</p><p>Methylphenidate (Ritalin)</p></td></tr><tr><td><p>Anticholinergics</p></td><td><p>Trihexyphenidyl (Artane)</p><p>Benztropine (Cogentin)</p></td><td><p>Diphenhydramine (Benadryl)</p></td></tr><tr><td><p>Antiemetics</p></td><td><p>Prochlorperazine (Compazine)</p></td><td><p>Metoclopramide (Reglan)</p></td></tr><tr><td><p>Antiepileptics</p></td><td><p>Phenytoin (Dilantin)</p><p>Carbamazepine (Tegretol)</p></td><td><p>Valproic Acid (Depakote)</p><p>Phenobarbital (Luminal)</p></td></tr><tr><td><p>Benzos</p></td><td><p>Alprazolam (Xanax)</p><p>Chlordiazepoxide (Librium)</p><p>Clonazepam (Klonopin)</p></td><td><p>Clorazepate (Tranxene)</p><p>Diazepam (Valium)</p><p>Lorazepam (Ativan)</p></td></tr><tr><td><p>Calcium Channel Blockers</p></td><td><p>Amlodipine (Norvasc)</p><p>Diltiazem (Cardizem)</p><p>Nicardipine (Cardene)</p></td><td><p>Nimodipine (Nimotop)</p><p>Verapamil (Calan)</p></td></tr><tr><td><p>Neuroleptics</p></td><td><p>Aripiprazole (Abilify)</p><p>Haloperidol (Haldol)</p><p>Olanzapine (Zyprexa)</p></td><td><p>Pimozode (Orap)</p><p>Ripseridone (Risperdal)</p><p>Ziprasidone (Geodon)</p></td></tr><tr><td><p>Tricyclic Antidepressants</p></td><td><p>Amitriptyline (Elavil)</p><p>Clomipramine (Anafranil)</p><p>Desipramine (Norpramin)</p></td><td><p>Imipramine (Tofranil)</p><p>Nortriptyline (Pamelor)</p></td></tr><tr><td><p>Other</p></td><td><p>Amantadine (Symmetrel)</p><p>Bismuth</p><p>Clonidine (Catapres)</p></td><td><p>L-Dopa (Sinemet)</p><p>Lithium (Lithobid)</p><p>Oral contraceptives</p></td></tr></tbody></table></div><p><strong>DDX Chronic Chorea</strong></p><div class=\"table-wrap\"><table><tbody><tr><td><p>Etiology</p></td><td><p>Examples</p></td><td></td></tr><tr><td><p><strong>Primary</strong></p></td><td><p>Benign hereditary chorea (incl. syndrome of choreoathetosis, hypothroidism, neonatal respiratory distress)</p></td><td></td></tr><tr><td><p><strong>Vascular/Hypoxic ischemic</strong></p></td><td><p>Stroke</p><p>Third trimester, pregnancy or perinatal hypoxic ischemic injuries leading to choreoathetoid CP</p></td><td></td></tr><tr><td><p><strong>Infectious</strong></p></td><td><p>Postencephalitis</p></td><td></td></tr><tr><td><p><strong>Malformations</strong></p></td><td><p>Joubert syndrome</p><p>Holoprosencephaly</p></td><td><p>Agenesis of CC</p></td></tr><tr><td><p><strong>Fixed</strong></p></td><td><p>Trauma</p></td><td><p>Kernicterus</p></td></tr><tr><td><p><strong>Minor or late</strong></p></td><td><p>Ceroid-lipofucinosis</p></td><td></td></tr><tr><td><p><strong>Genetic Neurodegenerative</strong></p></td><td><p>Ataxia Telangiectasia</p><p>Acyl-CoA Dehydrogenase def</p><p>Basal Ganglia Calcification (Fahr‚Äôs Disease)</p><p>Behcet Disease</p><p>Biopterin-depedent hyperphenylalaninemia</p><p>Canavan‚Äôs Disease</p><p>Ceroid Lipofuscinosis</p><p>Dentatorubro-pallidoluysian atrophy (DRPLA)</p><p>Friedreich Ataxia</p><p>Galactosemia</p><p>Gangliosidosis</p><p>Glutaric Aciduria</p></td><td><p>Huntington‚Äôs Disease</p><p>Lesch-Nyhan Disease Metachromatic Leukodystrophy</p><p>Methylmalonic aciduria</p><p>Mitochondrial Cytopathies</p><p>Neuroacanthocytosis</p><p>Niemann Pick Type C</p><p>Nonketotic Hyperglycinemia</p><p>Pelizaeus-Merzbacher Disease</p><p>Phenylketonuria</p><p>Propionic acidemia</p><p>PKAN and HARP syndrome</p><p>Rett Syndrome</p><p>Vitamin E def or malabsorption</p><p>Wilson‚Äôs Disease</p></td></tr></tbody></table></div><div class=\"table-wrap\"><table><tbody><tr><td><p><strong>WORK UP FOR CHOREA</strong></p></td><td></td></tr><tr><td><p>ASO/Anti DNAase B</p><p>CRP/ESR</p><p>ANA/Antiphospholipid antibodies</p><p>TFTs</p><p>CBC</p><p>CMP</p></td><td><p>Serum Ceruloplasmin</p><p>Serum Copper</p><p>Brain MRI</p><p>Other infxns to consider</p><p>       HSV, Lyme, HIV, WNV,     </p><p>       Mycoplasma, Legionnaire</p></td></tr></tbody></table></div><p><strong>Treatment (refer to medication dosing table at the end of the dystonia pathway for specifics):</strong></p><ul><li>Levetiracetam, Amantadine, Diazepam, Valproic Acid, Tetrabenazine and Neuroleptics (such as Risperdal) if severely disabling.</li></ul><p><strong>Sydenham chorea</strong></p><ul><li>Echo and EKG</li><li>Pencillin (or other abx)<ul><li>Secondary prevention of GABHS to reduce the risk of future infections and cardiac involvement, typically until 40 years of age</li></ul></li></ul><p>Anti-chorea</p><ul><li>Benzos</li><li>Keppra </li><li>VPA</li><li>Dopamine receptor blocking agents</li><li>Do not use anticholinergic as those can increase chorea</li></ul><p>Immune modulatory in severe cases</p><ul><li>Home treatment use po prednisone 2 mg/kg/day x 4 weeks with taper better than placebo</li><li>Inpatient treatment use IVIG or PLEX if incomplete response to IV steroids or contra-indication to steroids</li></ul><h1 id=\"tics\">Tics</h1><p><strong>resources: </strong><a href=\"https://tourette.org/\"><strong>https://tourette.org</strong></a></p><div class=\"table-wrap\"><table><tbody><tr><td><p><strong>DSM ‚Äì IV TR Diagnostic criteria for tic disorders</strong></p></td><td></td><td></td></tr><tr><td><p><strong>Transient Tic Disorder</strong></p></td><td><p><strong>Chronic Tic Disorder</strong></p></td><td><p><strong>Tourette‚Äôs Syndrome</strong></p></td></tr><tr><td><p>Onset before 18 years, typically age 4-6</p></td><td><p>Onset before 18 years, typically age 4-6</p></td><td><p>Onset before 18 years, typically age 4-6</p></td></tr><tr><td><p>Single or multiple motor <em>and/or </em>vocal tics</p></td><td><p>Multiple motor <em>or </em>vocal tics</p></td><td><p>Multiple motor <em>and</em> vocal tics, although need not be simultaneously present, for &gt;12 months</p></td></tr><tr><td><p>Tics occur many times a day, nearly every day for <em>at least 4 weeks but not more than 12 consecutive months</em></p></td><td><p>Tics occur many times a day, nearly every day for <em>greater than one year, with no more than 3 consecutive tic-free months</em> during that period</p></td><td><p>Tics occur many times a day, nearly every day for <em>greater than one year, with no more than 3 consecutive tic-free months</em> during that period</p></td></tr><tr><td><p>Not caused by the effect of a substance (for example, stimulants) or general medical condition (such as Huntington‚Äôs disease)</p></td><td><p>Not caused by the effect of a substance (for example, stimulants) or general medical condition (such as Huntington‚Äôs disease)</p></td><td><p>Not caused by the effect of a substance (for example, stimulants) or general medical condition (such as Huntington‚Äôs disease)</p></td></tr><tr><td><p>Does not fulfill criteria for Chronic Tic Disorder or Tourette‚Äôs Syndrome</p></td><td><p>Does not fulfill criteria for Tourette‚Äôs syndrome</p></td><td></td></tr></tbody></table></div><div class=\"table-wrap\"><table><tbody><tr><td><p><strong>DDX for Tics</strong></p></td><td></td></tr><tr><td><p>Akathisia</p></td><td><p>Paroxysmal Kinesigenic Dyskinesia</p></td></tr><tr><td><p>Chorea</p></td><td><p>Psychogenic Movements</p></td></tr><tr><td><p>Compulsions</p></td><td><p>Restless Leg Syndrome</p></td></tr><tr><td><p>Dystonia</p></td><td><p>Stereotypies</p></td></tr><tr><td><p>Myoclonus</p></td><td><p>Tardive Dyskinesia</p></td></tr></tbody></table></div><p><strong>Keys to functional tic like movements: sudden onset, teen female onset, multiple different tics at onset, coprolalia and copropraxia, complex motor and vocal tics, less frequently report an urge, tics don‚Äôt start oral motor facial, but rather big arm movements</strong>.</p><div class=\"callout-box\"><p><strong>Non-medication approaches to Tic Treatment</strong></p>\n<p>Educate patient, family, school teachers and coaches</p>\n<p>Tic Breaks</p>\n<p>Habit Reversal Training</p>\n<p>Stress Reduction Techniques: </p><p>  -Self-Hypnosis</p><p>  -Progressive Relaxation</p><p>  -Measured Breathing</p><p>  -Visualization</p>\n<p>Vitamin Supplements: </p><p>  -Magnesium</p><p>  -Riboflavin</p><p>  -CoEnzyme Q10</p><p>- Avoid excess sugar</p></div><p>*Treating underlying stress, i.e. ADHD, can help reduce the tics</p><p><strong>Medications for Tics</strong></p><div class=\"table-wrap\"><table><tbody><tr><td><p><strong>Med</strong></p></td><td><p><strong>Start dose</strong></p></td><td><p><strong>Titrate/goal/max</strong></p></td><td><p><strong>SEs</strong></p></td><td><p><strong>Comments</strong></p></td></tr><tr><td><p><em>TIER 1: alpha-2-adrenergic agonists</em></p></td><td></td><td></td><td></td><td></td></tr><tr><td><p>Clonidine</p><p>(Kapvay)</p><p> 0.1 mg tablets</p></td><td><p>0.05 mg at bedtime</p></td><td><p>Inc by 0.05 mg every 3-7 days </p><p>Goal:  0.05 mg every am, 0.05 mg mid-day, 0.1 mg every night Max: 0.4 mg per day</p></td><td><p>Sleepiness, Lightheadedness, Irritability, Ataxia, Low BP</p></td><td><p>-May benefit ADHD/aggression/ insomnia</p><p>-May be used with stimulants</p><p>-patch available</p></td></tr><tr><td><p>Guanfacine (Intuniv)</p><p>1 mg tabs</p></td><td><p>0.5 mg at bedtime</p></td><td><p>Increase by 0.5 mg every 3-7 days </p><p>Goal: 1 mg BID</p><p>Max: 2 mg BID</p></td><td><p>Sleepiness, Lightheadedness, Irritability,</p><p> Low BP</p></td><td><p>-May benefit ADHD/ aggression/ insomnia</p><p>-poss. less irritability than clonidine</p></td></tr><tr><td><p><em>TIER 2: benzodiazepines, antiseizure meds, dopamine-agonists, muscle relaxants, SSRIs, and Selective Norepinephrine Reuptake Inhibitors</em></p></td><td></td><td></td><td></td><td></td></tr><tr><td><p> Clonazepam</p></td><td><p>0.25 mg at bedtime</p></td><td><p>Increase by 0.25 mg every 3-7 days </p><p>Goal: 0.5 mg TID</p><p>Max: 2 mg TID</p></td><td><p>Sleepiness, Irritability</p></td><td><p>-Sleepiness usually resolves after 2 weeks</p><p>- abrupt withdrawal may result in szs</p></td></tr><tr><td><p>Levetiracetam</p></td><td><p>10-20 mg/kg/day div TID</p></td><td><p>Increase by 10 mg/ kg/DAY q 3-7 days </p><p>Goal: 30-50 mg/kg/DAY div TID</p><p>Max: 100 mg/kg/DAY div TID</p></td><td><p>Sleepiness, Irritability, Hyperkinesis</p></td><td><p>-Irritability may improve over time or with addition of 50-100mg of B6/day</p></td></tr><tr><td><p>Topiramate</p></td><td><p>25 mg at bedtime</p></td><td><p>Increase by 25 mg every 3-7 days </p><p>Goal: 50 mg BID</p><p>Max: 100 mg BID</p></td><td><p>Insomnia, Cognitive slowing, Anorexia</p></td><td><p>-May be useful if headaches present</p></td></tr><tr><td><p>Ropinerole</p></td><td><p>0.25 mg at bedtime</p></td><td><p>Increase by 0.25 mg every 2 weeks </p><p>Goal: 0.5 mg BID</p><p>Max: 12 mg BID</p></td><td><p>Nausea, Sleepiness, Compulsions, Lightheaded, Peripheral Edema</p></td><td><p>-May cause sudden sleep attacks</p><p>-Must monitor for compulsive eating, spending, organizing, sexual behav gambling</p><p>-May help RLS</p></td></tr><tr><td><p>Baclofen</p></td><td><p>5 mg at bedtime</p></td><td><p>Increase by 5 mg every 3-7 days</p><p>Goal: 10-20 mg TID</p><p>Max: 40 mg TID</p></td><td><p>Sleepiness</p></td><td><p>-May help with co-morbid spasticity</p><p>- May inc underlying weakness if present</p></td></tr><tr><td><p>Sertraline</p></td><td><p>25 mg at bedtime</p></td><td><p>Increase by 25 mg every 1-2 weeks </p><p>Goal: 50-150 mg per day</p><p>Max: 200 mg per day</p></td><td><p><strong>Suicidality, Mania, Insomnia</strong>, GI, Dizzy, Tremor, HA, Anxiety</p></td><td><p>-Useful if significant anxiety or OCD</p></td></tr><tr><td><p>Fluoxetine</p></td><td><p>10 mg at bedtime</p></td><td><p>Increase by 10 mg every 1-2 weeks </p><p>Goal: 40-60 mg per day</p><p>Max: 80 mg per day</p></td><td><p><strong>Suicidality, Mania, </strong>Insomnia, GI, Tremor, Anxiety, Dizziness, HA</p></td><td><p>-Useful if significant anxiety or OCD</p></td></tr><tr><td><p>Atomoxetine</p></td><td><p>0.5 mg/kg at breakfast</p></td><td><p>Increase to goal after minimum of 3 days</p><p>Goal: 1.2 mg/kg/DAY</p><p>Max: 1.8 mg/kg/DAY or 100 mg per day, whichever is lower</p></td><td><p>Wt loss, Sedation, Insomnia, Anxiety, Depression, <strong>Suicide, Mania, Sudden cardiac death</strong></p></td><td><p>-May be used if ADHD also present</p><p>-May give at bedtime if sedation occurs</p><p>-Divide twice daily if nausea occurs</p></td></tr><tr><td><p><em>TIER 3: dopamine re-uptake inhibitors and dopamine-receptor blockers</em></p></td><td></td><td></td><td></td><td></td></tr><tr><td><p>  Tetrabenazine</p></td><td><p>12.5 mg at bedtime</p></td><td><p>&nbsp;Increase by 12.5 mg weekly</p><p>Goal: 25 mg TID</p><p>Max: 50 mg TID</p></td><td><p>Sedation, Anxiety, Akathisia, Wt gain <strong>Depression, Psychosis/Suicide, </strong>Acute Dystonic Rxn, Parkinsonism</p></td><td><p>-NO RISK of tardive dyskinesia</p><p>-If any depression, should monitor closely with a psychiatrist</p></td></tr><tr><td><p>  Risperidone</p></td><td><p>0.25-0.5 mg at bedtime</p></td><td><p>&nbsp;Increase by 0.5 mg every 1-2 weeks</p><p>Goal: 1 mg BID</p><p>Max: 4 mg per day</p></td><td><p>&nbsp;<strong>Wt gain, </strong>Insomnia or Sedation, Anxiety, HA, Gynecomastia, EPS, <strong>Tardive Dyskinesia</strong></p></td><td><p><strong>-May prolong QTc</strong></p></td></tr><tr><td><p>  Olanzapine</p></td><td><p>1.25 mg at bedtime</p></td><td><p>Increase by 1.25 mg every 1-2 weeks</p><p>Goal: 2.5 mg BID</p><p>Max: 5 mg BID</p></td><td><p>&nbsp;Wt gain<strong>, </strong>Sedation, Orthostatic Hypotension, Edema, GI, Gynecomastia, EPS, <strong>Tardive Dyskinesia</strong></p></td><td><p><strong>-May prolong QTc</strong></p></td></tr><tr><td><p>  Ziprasidone</p></td><td><p>20 mg at bedtime</p></td><td><p>&nbsp;Increase by 20 mg every 1-2 weeks</p><p>Goal: 40 mg per day;   <strong>Max: 80 mg per day</strong></p></td><td><p>&nbsp;<strong>Sedation, </strong>Anxiety, Depression, Wt gain, EPS, <strong>Tardive Dyskinesia</strong></p></td><td><p>-<strong>May prolong QTc</strong></p></td></tr><tr><td><p>  Haloperidol</p></td><td><p>0.25-0.5 mg at bedtime</p></td><td><p>&nbsp;Increase by 0.25-0.5 mg every 5-7 days</p><p>Goal: 0.05-0.075 mg/kg/DAY div BID/TID</p><p>Max: 0.15 mg/kg/DAY</p></td><td><p>&nbsp;Wt gain, Bulimia<strong>, </strong>Sedation, Anxiety, Depression, Dysphoria, Cognitive, Phobia, EPS, <strong>Tardive Dyskinesia</strong></p></td><td><p><strong>-May prolong QTc</strong></p><p>-May also cause acute dystonic rxn</p><p>-High risk for extra-pyramidal sxs</p><p>-Very effective for reducing tics</p></td></tr><tr><td><p>  Pimozide</p></td><td><p>0.25-0.5 mg at bedtime</p></td><td><p>&nbsp;Increase by 0.5 mg every 1-2 weeks</p><p>Goal: 1 mg BID</p><p>Max: 5 mg BID</p></td><td><p>&nbsp;Weight gain<strong>, </strong>Sedation, Anxiety, Depression, Parkinsonism, <strong>Tardive Dyskinesia</strong></p></td><td><p>-Acute dystonic rxn</p><p>-Can cause <strong>fatal arrhythmias due to prolonged QTc,</strong> esp when combined w/ some OTC meds</p><p>- Very effective</p></td></tr></tbody></table></div>",
  "imageCount": 2,
  "chunkCount": 8
}